浙江华义制药有限公司
Hangzhou Huadong Medicine Group Zhejiang Huayi Pharmaceutical Co. Ltd. Yiwu Cn
Country: CN CDE+CEP MEDIUM
🇨🇳 CDE
19
19 products shown
🇺🇸 DMF
0
0 products shown
🇪🇺 CEP
8
8 products shown
Total
27
registrations
🇨🇳 CDE 注册 (19)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Apremilast 阿普斯特 | 608141-41-9 | Class A | Y20210000113 |
| Belumosudil 甲磺酸贝舒地尔 | 911417-87-3 | Class I | Y20250000081 |
| Canagliflozin 卡格列净 | 842133-18-0 | Class A | Y20200001023 |
| Ciprofloxacin 盐酸环丙沙星 | 85721-33-1 | Class A | Y20190002570 |
| Empagliflozin 恩格列净 | 864070-44-0 | Class A | Y20190021274 |
| Febuxostat 非布司他 | 144060-53-7 | Class A | Y20170001633 |
| Ibrutinib 伊布替尼 | 936563-96-1 | Class A | Y20240000629 |
| Macitentan 马昔腾坦 | 441798-33-0 | Class A | Y20200001281 |
| Mifanertinib 马来酸美凡厄替尼 | 1057-56-3 | Class A | Y20240000399 |
| Mirabegron 米拉贝隆 | 223673-61-8 | Class A | Y20190000765 |
| Morponidazole 吗啉硝唑 | 92478-27-8 | Class A | Y20230001123 |
| Omeprazole 奥美拉唑 | 73590-58-6 | Class A | Y20190008313 |
| Omeprazole Sodium 奥美拉唑钠 | 73590-58-6 | Class A | Y20190007218 |
| Ozenoxacin 奥泽沙星 | 245765-41-7 | Class I | Y20220000207 |
| Regorafenib 瑞戈非尼 | 755037-03-7 | Class A | Y20220000148 |
| Selexipag 司来帕格 | 475086-01-2 | Class A | Y20220001259 |
| Simvastatin 辛伐他汀 | 79902-63-9 | Class A | Y20190002257 |
| Solifenacin 琥珀酸索利那新 | 242478-37-1 | Class A | Y20180000737 |
| Tofacitinib 伊托法替布 | 477600-75-2 | Class A | Y20200001214 |
🇪🇺 CEP 注册 (8)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Ciprofloxacin Hydrochloride 盐酸乳酸环丙沙星 | 93107-08-5 | R1-CEP 2006-045 - Rev 01 | - |
| Clarithromycin 克拉霉素 | 81103-11-9 | R1-CEP 2005-302 - Rev 00 | - |
| Duloxetine Hydrochloride 盐酸度洛西汀 | 136434-34-9 | CEP 2015-155 - Rev 01 | - |
| Esomeprazole Magnesium Trihydrate 埃索美拉唑镁三水合物 | 73590-58-6 | R0-CEP 2014-318 - Rev 00 | - |
| Levetiracetam 左乙拉西坦 | 102767-28-2 | CEP 2011-035 - Rev 04 | - |
| Mirabegron 米拉贝隆 | 223673-61-8 | CEP 2024-037 - Rev 00 | - |
| Omeprazole 奥美拉唑 | 73590-58-6 | CEP 2012-326 - Rev 01 | - |
| Pioglitazone Hydrochloride 盐酸吡格列酮 | 112529-15-4 | R0-CEP 2013-096 - Rev 00 | - |
Source: ema_cep;FDA_DMF | Updated: 2026-04-09 07:23:02